EverydayHealthLogo
Dr. Nelson Teng, MD

Dr. Nelson Teng, MD

Stanford, CA

42 Years of Experience

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Teng, Obstetrician / Gynecologist (OBGYN) in Stanford, CA?

    Dr. Nelson Teng, MD is an Obstetrician / Gynecologist (OBGYN), who primarily practices in Stanford, CA with 1 additional practice location. He has been practicing for over 42 years and is board certified. Dr. Teng completed his residency at Ucla Med Ctr, Obstetrics And Gynecology. Dr. Teng is fluent in English and Chinese, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Teng’s office at (650) 498-8080.

    What are Areas of Expertise for Dr. Teng?

    Dr. Nelson Teng, MD is a highly-rated, board-certified Obstetrician / Gynecologist (OBGYN) known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Teng empowers patients to confidently navigate their health journey, specializing in Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Uterine Cancer, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Teng is dedicated to enhancing lives through expert, patient-centered care.

    Where did Dr. Teng go to medical school and complete their residency?

    • Fellowship: Stanford University School of Medicine CA | Stanford University School of Medicine,Stanford, Ca, United States

    • Residency: Ucla Med Ctr, Obstetrics And Gynecology | UCLA Medical Center | University of California, Los Angeles

    • Medical School: University of Miami Sch of Med, Miami Fl

    Is Dr. Teng board certified as an Obstetrician / Gynecologist (OBGYN)?

    Yes, Dr. Nelson Teng, MD is board certified by the American Board of Obstetrics and Gynecology , American Board of Obstetrics and Gynecology since 1987, American Board of Obstetrics and Gynecology since 1985

    What languages does Dr. Teng speak?

    Dr. Teng and their clinical team can communicate with patients in the following languages:

    • Chinese

    • English

    What conditions does an Obstetrician / Gynecologist (OBGYN) like Dr. Teng typically treat?

    What procedures does an Obstetrician / Gynecologist (OBGYN) like Dr. Teng typically perform?

    As an Obstetrician / Gynecologist (OBGYN), procedures performed by Dr. Nelson Teng may include:

    Please contact Dr. Teng's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.

    Does Dr. Teng accept my insurance?

    Please contact Dr. Teng's office to confirm accepted insurance plans.

    Where is Dr. Teng's office located?

    Sumc Ob Gyn Dept

    300 Pasteur Dr

    Stanford, CA 94305

    (650) 498-8080

    Get Directions

    Dr. Nelson Teng's Practice 2

    900 Blake Wilbur Dr

    Palo Alto, CA 94304

    Get Directions

    Recognitions

    Publications

    The CD47-sigl regulatory protein alpha

    , 2012

    Wnt and Hedgehog Gene Pathway Expression in Serous Ovarian Cancer

    , 2011

    Gynecologic maligncies in female-to-male transgender patients

    , 2011

    Squamous Cell Carcinoma Arising From Mature Cystic Teratoma of the Ovary

    , 2011

    INTRAOPERATIVE RADIATION THERAPY FOR LOCALLY ADVANCED AND RECURRENT SOFT-TISSUE SARCOMAS IN ADULTS

    , 2008

    Integrative proteomic

    , 2008

    Ovarian cancer. Clinical practice guidelines in oncology.

    , 2008

    tural frequency alysis of tooth stability under various simulated types

    , 2008

    Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid

    , 2008

    Trends in demographic and clinical characteristics in women diagnosed with corpus cancer

    , 2008

    Ovarian clear cell carcinoma with papillary features

    , 2008

    A novel technique for the enrichment of primary ovarian cancer cells

    , 2007

    Long-term survivors using intraoperative radiotherapy for recurrent gynecologic maligncies

    , 2007

    The potential therapeutic role of lymph node resection in epithelial ovarian cancer

    , 2007

    Prognostic factors for outcomes

    , 2007

    Effects of human monoclol antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro

    , 2007

    Safety and efficacy of lelidomide (Revlimid((R)))

    , 2007

    Prognostic factors responsible for survival in sex cord stromal tumors of the ovary

    , 2007

    Ovarian cancer in younger vs older women: a population-based alysis

    , 2006

    Ovarian cancer. Clinical practice guidelines in oncology.

    , 2006

    Uterine cancers.

    , 2006

    Uterine papillary serous

    , 2006

    Improved survival of Asians with corpus cancer compared with whites

    , 2006

    Intraoperative radiation therapy in recurrent ovarian cancer

    , 2005

    Impact of adjuvant therapy on survival of patients with early

    , 2005

    A modified technique for insertion of intraperitoneal port for chemotherapy

    , 2005

    Cervical cancer guidelines. Clinical practice guidelines in oncology.

    , 2004

    Differential expression of CD40 and CD95 in ovarian carcinoma

    , 2004

    Epoxidation of chiral camphor N-enoylpyrazolidinones with methyl

    , 2003

    Modification of the vertical rectus abdominis musculocutaneous

    , 2003

    Preoperative CT diagnosis of primary fallopian tube carcinoma

    , 2003

    VH4-34 encoded antibody in systemic lupus erythematosus: Effect of Isotype

    , 2002

    A new approach to enhancement of bone formation by electrically polarized hydroxyapatite

    , 2001

    Effect of 17 beta-estradiol or alendrote on the bone densitometry

    , 2001

    Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy

    , 2000

    Recognition of auto- and exoantigens by V4-34 gene encoded antibodies

    , 2000

    Primary leiomyosarcoma of the vagi. A case report and literature review.

    , 2000

    Malignt granular cell tumor of the vulva in a 17-year-old: Case report and literature review.

    , 2000

    VH4-34 encoded antibodies in systemic lupus erythematosus

    , 1999

    Clinical practice guidelines in the magement of gynecologic maligncies

    , 1999

    Cytotoxicity of murine B lymphocytes induced by human VH4-34

    , 1997

    Rapid cytotoxicity of human B lymphocytes induced by VH4-34

    , 1997

    V(H)4-34(V(H)4.21) gene expression in the chronic arthritides of childhood

    , 1996

    NCCN Ovarian Cancer Practice Guidelines. The tiol Comprehensive Cancer Network.

    , 1996

    Rapid cytotoxicity of human B lymphocytes induced by VH4-34

    , 1996

    Phase 1 trial of intraperitoneal AD-32 in gynecologic maligncies

    , 1996

    Operative laparoscopy in the magement of ovarian cancer

    , 1996

    ANTIENDOTOXIN HUMAN MONOCLOL-ANTIBODY A6H4C5 (HA-1A) UTILIZES THE VH4.21 GENE

    , 1995

    HUMAN CD5+ B-LYMPHOCYTES (B-1 CELLS) DECREASE IN PERIPHERAL-BLOOD DURING PREGNCY

    , 1995

    THE ROLE OF LAPAROSCOPY IN THE MAGEMENT OF GYNECOLOGIC MALIGNCY

    , 1994

    FACS ALYSIS OF PERITONEAL LYMPHOCYTES IN OVARIAN-CANCER AND CONTROL PATIENTS

    , 1994

    HUMAN ANTILIPID A MONOCLOL-ANTIBODIES BIND TO HUMAN B-CELLS AND THE I-ANTIGEN ON CORD

    , 1993

    PERITONEAL IMPLANT ELIMITION DURING CYTOREDUCTIVE SURGERY FOR OVARIAN-CANCER - IMPACT ON SURVIVAL

    , 1993

    DOCUMENTATION OF COMPLETE RESOLUTION OF GESTATIOL CHORIOCARCINOMA IN THE OOPHORECTOMIZED PATIENT

    , 1993

    LIPOPOLYSACCHARIDE AND PEPTIDOGLYCAN SHARE BINDING-SITES ON HUMAN PERIPHERAL-BLOOD MONOCYTES

    , 1993

    ONE-STEP ENRICHMENT OF NUCLEATED RED-BLOOD-CELLS - A POTENTIAL APPLICATION IN PERITAL DIAGNOSIS

    , 1993

    Adenocarcinoma-reactive human monoclol antibody MS2B6 defines an antigen in simple gl

    , 1992

    HUMAN MONOCLOL-ANTIBODY RECOGNIZING AN ANTIGEN ASSOCIATED WITH OVARIAN AND OTHER ADENOCARCINOMAS

    , 1992

    THE ONTOGENY AND FUNCTIOL-CHARACTERISTICS OF HUMAN B-1 (CD5+B) CELLS

    , 1992

    TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SEPTIC SHOCK WITH HA

    , 1991

    WOMEN WITH PREECLAMPSIA HAVE HIGHER PLASMA ENDOTHELIN LEVELS THAN WOMEN WITH NORMAL PREGNCIES

    , 1990

    ONE-STEP SEPARATION OF HUMAN FETAL LYMPHOCYTES FROM NUCLEATED RED-BLOOD-CELLS

    , 1990

    INITIAL EVALUATION OF A HUMAN IMMUNOGLOBULIN-M MONOCLOL-ANTIBODY (HA-1A) IN HUMANS

    , 1990

    A RANDOMIZED COMPARATIVE TRIAL OF CARBOPLATIN AND IPROPLATIN IN ADVANCED SQUAMOUS CARCINOMA

    , 1989

    RADIATION-THERAPY FOR PRIMARY SQUAMOUS-CELL CARCINOMA OF THE VAGI - STANFORD-UNIVERSITY EXPERIENCE

    , 1989

    DELETION OF HISTO-BLOOD GROUP

    , 1989

    EFFECTS OF ANTI-LIPID A HUMAN MONOCLOL

    , 1989

    TOPICAL INTERFERON FOR TREATING CONDYLOMA ACUMITA IN WOMEN

    , 1988

    GENERATION OF HUMAN MONOCLOL-ANTIBODIES TO CANCER

    , 1987

    SINGLE-DOSE ACTINOMYCIN

    , 1987

    CLINICAL-APPLICATIONS OF MONOCLOL-ANTIBODIES IN GYNECOLOGIC ONCOLOGY

    , 1987

    THE EFFECT OF HUMAN ANTIENDOTOXIN MONOCLOL-ANTIBODIES ON ENDOTOXIN-INDUCED LUNG INJURY IN THE RAT

    , 1987

    EPITHELIAL OVARIAN-CARCINOMA IN PATIENTS WITH INTERSEX DISORDERS

    , 1986

    INFLUENCE OF AVIDITY AND IDIOTOPE RECOGNITION ON THE MODULATION OF SURFACE

    , 1986

    PROTECTION AGAINST GRAM-NEGATIVE BACTEREMIA AND ENDOTOXEMIA WITH HUMAN MONOCLOL IGM ANTIBODIES

    , 1985

    ANTIBODIES TO PEPTIDES CORRESPONDING TO A CONSERVED SEQUENCE OF GONOCOCCAL PILINS BLOCK BACTERIAL

    , 1985

    PRODUCTION OF HUMAN MONOCLOL IGG ANTIBODIES AGAINST RHESUS (D) ANTIGEN

    , 1984

    PARTIAL HYDATIDIFORM MOLE WITH DIPLOID KARYOTYPE - REPORT OF 3 CASES

    , 1984

    SOMATIC-CELL HYBRID SELECTION WITH A TRANSFECTABLE DOMINT MARKER

    , 1984

    MONOCLOL VERSUS POLYCLOL ANTIBODY-RADIOIMMUNOASSAY AGAINST THE BETA

    , 1983

    CONSTRUCTION AND TESTING OF MOUSE HUMAN HETEROMYELOMAS FOR HUMAN MONOCLOL-ANTIBODY PRODUCTION

    , 1983

    CHARACTERIZATION OF AN ALPHA-BUNGAROTOXIN BINDING COMPONENT FROM DROSOPHILA - MELANOGASTER

    , 1977

    APPEARANCE OF ACETYLCHOLINE RECEPTORS IN CULTURED MYOBLASTS PRIOR TO FUSION

    , 1976

    Taxol-oligoarginine conjugates overcome drug resistance in-vitro in human ovarian carcinoma

    , 2012

    The CD47-signal regulatory protein alpha

    , 2012

    Prox-1, Podoplanin and HPV staining assists in identification of lymphangioma circumscriptum of the

    , 2011

    Wnt and Hedgehog Gene Pathway Expression in Serous Ovarian Cancer

    , 2011

    Gynecologic malignancies in female-to-male transgender patients

    , 2011

    The incidence of isolated para

    , 2011

    Squamous Cell Carcinoma Arising From Mature Cystic Teratoma of the Ovary

    , 2011

    Leukemia inhibitory factor downregulates human papillomavirus-16 oncogene expression

    , 2011

    INTRAOPERATIVE RADIATION THERAPY FOR LOCALLY ADVANCED AND RECURRENT SOFT-TISSUE SARCOMAS IN ADULTS

    , 2008

    Integrative proteomic

    , 2008

    Ovarian cancer. Clinical practice guidelines in oncology.

    , 2008

    Natural frequency analysis of tooth stability under various simulated types

    , 2008

    Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid

    , 2008

    Trends in demographic and clinical characteristics in women diagnosed with corpus cancer

    , 2008

    Ovarian clear cell carcinoma with papillary features

    , 2008

    Cervical cancer screening.

    Cervical cancer.

    A novel technique for the enrichment of primary ovarian cancer cells

    , 2007

    Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies

    , 2007

    Acute postoperative thrombotic thrombocytopenic purpura following hysterectomy

    , 2007

    The potential therapeutic role of lymph node resection in epithelial ovarian cancer

    , 2007

    Lymphadenectomy in endometrioid uterine cancer staging

    , 2007

    Influence of the gynecologic oncologist on the survival of ovarian cancer patients

    , 2007

    Prognostic factors for outcomes

    , 2007

    Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro

    , 2007

    Safety and efficacy of lenalidomide (Revlimid((R)))

    , 2007

    Prognostic factors for uterine cancer in reproductive-aged women

    , 2007

    Prognostic factors responsible for survival in sex cord stromal tumors of the ovary

    , 2007

    Association of lymphadenectomy and survival in stage I ovarian cancer patients

    , 2007

    Disruption of actin filaments by latrunculin B affects cell wall construction

    , 2007

    Mesonephric adenocarcinoma of the cervix: A case report and review of the literature

    , 2006

    The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma

    , 2006

    Safety and efficacy of thalidomide in recurrent epithelial ovarian and peritoneal carcinoma

    , 2006

    Ovarian cancer in younger vs older women: a population-based analysis

    , 2006

    The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of

    , 2006

    Therapeutic role of lymph node resection in endometrioid corpus cancer - A study of 12,333 patients

    , 2006

    Ovarian cancer. Clinical practice guidelines in oncology.

    , 2006

    Outcomes of women with metachronous breast and ovarian carcinomas

    , 2006

    Breast cancer followed by corpus cancer: Is there a higher risk for aggressive histologic subtypes?

    , 2006

    Patterns and progress in ovarian cancer over 14 years

    , 2006

    Uterine cancers.

    , 2006

    Enhanced killing of primary ovarian cancer by retargeting autologous cytokine

    , 2006

    Uterine papillary serous

    , 2006

    Improved survival of Asians with corpus cancer compared with whites

    , 2006

    Elevated CO2 induces physiological

    , 2006

    Intraoperative radiation therapy in recurrent ovarian cancer

    , 2005

    Impact of adjuvant therapy on survival of patients with early

    , 2005

    A modified technique for insertion of intraperitoneal port for chemotherapy

    , 2005

    Cervical cancer guidelines. Clinical practice guidelines in oncology.

    , 2004

    Detection of pelvic lymph node micrometastasis in stage IA2

    , 2004

    Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma

    , 2004

    B cell lymphoproliferative disorders and VH4-34 gene encoded antibodies.

    , 2004

    Differential expression of CD40 and CD95 in ovarian carcinoma

    , 2004

    Epoxidation of chiral camphor N-enoylpyrazolidinones with methyl

    , 2003

    Modification of the vertical rectus abdominis musculocutaneous

    , 2003

    Gene expression patterns in ovarian carcinomas

    , 2003

    Preoperative CT diagnosis of primary fallopian tube carcinoma

    , 2003

    Liposomal doxorubicin for treatment of metastatic chemorefractory vulvar adenocarcinoma

    , 2002

    VH4-34 encoded antibody in systemic lupus erythematosus: Effect of Isotype

    , 2002

    A new approach to enhancement of bone formation by electrically polarized hydroxyapatite

    , 2001

    Effect of 17 beta-estradiol or alendronate on the bone densitometry

    , 2001

    Susceptibility of B-cell lymphoma to human antibodies encoded by the V4-34 gene

    , 2001

    Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy

    , 2000

    Recognition of auto- and exoantigens by V4-34 gene encoded antibodies

    , 2000

    Primary leiomyosarcoma of the vagina. A case report and literature review.

    , 2000

    Malignant granular cell tumor of the vulva in a 17-year-old: Case report and literature review.

    , 2000

    VH4-34 encoded antibodies in systemic lupus erythematosus

    , 1999

    Clinical practice guidelines in the management of gynecologic malignancies

    , 1999

    Cytotoxicity of murine B lymphocytes induced by human VH4-34

    , 1997

    Rapid cytotoxicity of human B lymphocytes induced by VH4-34

    , 1997

    Heavy chain variable gene usage by human B-1 lymphocytes and polyreactive autoantibodies.

    , 1997

    V(H)4-34(V(H)4.21) gene expression in the chronic arthritides of childhood

    , 1996

    Lymphangioleiomyomatosis of the uterus simulating high-stage endometrial stromal sarcoma

    , 1996

    NCCN Ovarian Cancer Practice Guidelines. The National Comprehensive Cancer Network.

    , 1996

    Rapid cytotoxicity of human B lymphocytes induced by VH4-34

    , 1996

    Phase 1 trial of intraperitoneal AD-32 in gynecologic malignancies

    , 1996

    Operative laparoscopy in the management of ovarian cancer

    , 1996

    The female genital tract.

    , 1996

    ANTIENDOTOXIN HUMAN MONOCLONAL-ANTIBODY A6H4C5 (HA-1A) UTILIZES THE VH4.21 GENE

    , 1995

    HUMAN CD5+ B-LYMPHOCYTES (B-1 CELLS) DECREASE IN PERIPHERAL-BLOOD DURING PREGNANCY

    , 1995

    THE ROLE OF LAPAROSCOPY IN THE MANAGEMENT OF GYNECOLOGIC MALIGNANCY

    , 1994

    FACS ANALYSIS OF PERITONEAL LYMPHOCYTES IN OVARIAN-CANCER AND CONTROL PATIENTS

    , 1994

    HUMAN ANTILIPID A MONOCLONAL-ANTIBODIES BIND TO HUMAN B-CELLS AND THE I-ANTIGEN ON CORD

    , 1993

    PERITONEAL IMPLANT ELIMINATION DURING CYTOREDUCTIVE SURGERY FOR OVARIAN-CANCER - IMPACT ON SURVIVAL

    , 1993

    DOCUMENTATION OF COMPLETE RESOLUTION OF GESTATIONAL CHORIOCARCINOMA IN THE OOPHORECTOMIZED PATIENT

    , 1993

    LIPOPOLYSACCHARIDE AND PEPTIDOGLYCAN SHARE BINDING-SITES ON HUMAN PERIPHERAL-BLOOD MONOCYTES

    , 1993

    LONG-TERM SURVIVAL WITH ADJUVANT WHOLE ABDOMINOPELVIC IRRADIATION FOR UTERINE PAPILLARY SEROUS

    , 1993

    ONE-STEP ENRICHMENT OF NUCLEATED RED-BLOOD-CELLS - A POTENTIAL APPLICATION IN PERINATAL DIAGNOSIS

    , 1993

    Adenocarcinoma-reactive human monoclonal antibody MS2B6 defines an antigen in simple gl

    , 1992

    HUMAN MONOCLONAL-ANTIBODY RECOGNIZING AN ANTIGEN ASSOCIATED WITH OVARIAN AND OTHER ADENOCARCINOMAS

    , 1992

    THE ONTOGENY AND FUNCTIONAL-CHARACTERISTICS OF HUMAN B-1 (CD5+B) CELLS

    , 1992

    CRITICAL REASSESSMENT OF 2ND LOOK EXPLORATORY LAPAROTOMY FOR EPITHELIAL OVARIAN-CARCINOMA

    , 1992

    MODIFIED POSTERIOR EXENTERATION FOR OVARIAN-CANCER

    , 1991

    OPTICAL BIOSENSOR ASSAY (OBA)

    , 1991

    QUANTITATIVE PROTEIN-CHANGES IN METASTATIC VERSUS PRIMARY EPITHELIAL OVARIAN-CARCINOMA

    , 1991

    TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SEPTIC SHOCK WITH HA

    , 1991

    Gynecologic factors in sexual dysfunction of the older woman.

    , 1991

    WOMEN WITH PREECLAMPSIA HAVE HIGHER PLASMA ENDOTHELIN LEVELS THAN WOMEN WITH NORMAL PREGNANCIES

    , 1990

    Synthesis and Characterization of Gentiobiose Heptaacetate Conjugate Vaccines That Produce

    , 1990

    STUDY OF THE SELECTIVE CYTOTOXIC PROPERTIES OF CATIONIC

    , 1990

    ONE-STEP SEPARATION OF HUMAN FETAL LYMPHOCYTES FROM NUCLEATED RED-BLOOD-CELLS

    , 1990

    DELIVERY OF A NORMAL INFANT FOLLOWING CISPLATIN, VINBLASTINE

    , 1990

    INITIAL EVALUATION OF A HUMAN IMMUNOGLOBULIN-M MONOCLONAL-ANTIBODY (HA-1A) IN HUMANS

    , 1990

    PROSPECTIVE RANDOMIZED TRIAL OF TOPICAL ALPHA-INTERFERON

    , 1990

    A RANDOMIZED COMPARATIVE TRIAL OF CARBOPLATIN AND IPROPLATIN IN ADVANCED SQUAMOUS CARCINOMA

    , 1989

    RADIATION-THERAPY FOR PRIMARY SQUAMOUS

    , 1989

    DELETION OF HISTO-BLOOD GROUP

    , 1989

    EFFECTS OF ANTI-LIPID A HUMAN MONOCLONAL

    , 1989

    TOPICAL INTERFERON FOR TREATING CONDYLOMA ACUMINATA IN WOMEN

    , 1988

    GENERATION OF HUMAN MONOCLONAL-ANTIBODIES TO CANCER

    , 1987

    CARDIOVASCULAR EFFECT OF INTRAVENOUS LIPID-A IN RABBITS

    , 1987

    SINGLE-DOSE ACTINOMYCIN

    , 1987

    CLINICAL-APPLICATIONS OF MONOCLONAL-ANTIBODIES IN GYNECOLOGIC ONCOLOGY

    , 1987

    THE EFFECT OF HUMAN ANTIENDOTOXIN MONOCLONAL-ANTIBODIES ON ENDOTOXIN-INDUCED LUNG INJURY IN THE RAT

    , 1987

    EPITHELIAL OVARIAN-CARCINOMA IN PATIENTS WITH INTERSEX DISORDERS

    , 1986

    INFLUENCE OF AVIDITY AND IDIOTOPE RECOGNITION ON THE MODULATION OF SURFACE

    , 1986

    A CRITICAL REASSESSMENT OF 2ND-LOOK LAPAROTOMY IN EPITHELIAL OVARIAN-CARCINOMA

    , 1986

    PROTECTION AGAINST GRAM-NEGATIVE BACTEREMIA AND ENDOTOXEMIA WITH HUMAN MONOCLONAL IGM ANTIBODIES

    , 1985

    ANTIBODIES TO PEPTIDES CORRESPONDING TO A CONSERVED SEQUENCE OF GONOCOCCAL PILINS BLOCK BACTERIAL

    , 1985

    PRODUCTION OF HUMAN MONOCLONAL IGG ANTIBODIES AGAINST RHESUS (D) ANTIGEN

    , 1984

    PARTIAL HYDATIDIFORM MOLE WITH DIPLOID KARYOTYPE - REPORT OF 3 CASES

    , 1984

    SOMATIC-CELL HYBRID SELECTION WITH A TRANSFECTABLE DOMINANT MARKER

    , 1984

    2ND-LOOK LAPAROTOMY IN EPITHELIAL OVARIAN-CARCINOMA - PRECISE DEFINITION, SENSITIVITY

    , 1984

    MONOCLONAL VERSUS POLYCLONAL ANTIBODY-RADIOIMMUNOASSAY AGAINST THE BETA

    , 1983

    CONSTRUCTION AND TESTING OF MOUSE HUMAN HETEROMYELOMAS FOR HUMAN MONOCLONAL-ANTIBODY PRODUCTION

    , 1983

    CHARACTERIZATION OF AN ALPHA-BUNGAROTOXIN BINDING COMPONENT FROM DROSOPHILA - MELANOGASTER

    , 1977

    APPEARANCE OF ACETYLCHOLINE RECEPTORS IN CULTURED MYOBLASTS PRIOR TO FUSION

    , 1976

    MITOGENICITY OF THROMBIN AND SURFACE ALTERATIONS ON MOUSE SPLENOCYTES

    What is Dr. Teng's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Teng's National Provider Identifier (NPI) number is 1245379510.

    What common questions do patients ask about Dr. Teng?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Teng

    What is Dr. Nelson Teng's specialty?

    Dr. Teng is a Obstetrician / Gynecologist (OBGYN) near Stanford, CA.

    What does an Obstetrician / Gynecologist (OBGYN) do?

    An obstetrician/gynecologist has specialized knowledge, skills, and expertise in the medical and surgical management of the female reproductive system and related disorders. This physician acts as a consultant to other healthcare providers while also serving as a primary care physician for women, addressing their unique health needs throughout various stages of life.

    Is this Dr. Nelson Teng affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Teng is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    When to see an Obstetrician / Gynecologist (OBGYN)?: Guides for symptoms, conditions, and treatments

    Understand your symptoms and know when it’s time to see an Obstetrician / Gynecologist (OBGYN). Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Nelson Teng accepting new patients in Stanford, CA?

    Yes, Dr. Nelson Teng is accepting new patients at this time.

    Does Dr. Nelson Teng offer online booking?

    Please contact Dr. Teng's office at (650) 498-8080 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Nelson Teng?

    Please contact Dr. Teng's office at (650) 498-8080 for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Nelson Teng have?

    Dr. Nelson Teng is certified by the American Board of Obstetrics and Gynecology.

    Other Obstetrician / Gynecologist (OBGYN) Near Stanford, CA

    SW

    Obstetrician / Gynecologist (OBGYN)

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    PM

    Obstetrician / Gynecologist (OBGYN)

    acceptingPatients-iconAccepting patients
    Stanford, CA
    MS

    Obstetrician / Gynecologist (OBGYN)

    acceptingPatients-iconAccepting patients
    Stanford, CA
    See All Specialists

    Doctors by Category

    Specialists